GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Apontis Pharma AG (XTER:APPH) » Definitions » Equity-to-Asset

Apontis Pharma AG (XTER:APPH) Equity-to-Asset : 0.53 (As of Dec. 2023)


View and export this data going back to 2021. Start your Free Trial

What is Apontis Pharma AG Equity-to-Asset?

Equity to Asset ratio is calculated as total stockholders equity divided by total asset. Apontis Pharma AG's Total Stockholders Equity for the quarter that ended in Dec. 2023 was €30.26 Mil. Apontis Pharma AG's Total Assets for the quarter that ended in Dec. 2023 was €57.46 Mil. Therefore, Apontis Pharma AG's Equity to Asset Ratio for the quarter that ended in Dec. 2023 was 0.53.

The historical rank and industry rank for Apontis Pharma AG's Equity-to-Asset or its related term are showing as below:

XTER:APPH' s Equity-to-Asset Range Over the Past 10 Years
Min: 0.12   Med: 0.36   Max: 0.75
Current: 0.53

During the past 6 years, the highest Equity to Asset Ratio of Apontis Pharma AG was 0.75. The lowest was 0.12. And the median was 0.36.

XTER:APPH's Equity-to-Asset is ranked worse than
55.57% of 1087 companies
in the Drug Manufacturers industry
Industry Median: 0.58 vs XTER:APPH: 0.53

Apontis Pharma AG Equity-to-Asset Historical Data

The historical data trend for Apontis Pharma AG's Equity-to-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Apontis Pharma AG Equity-to-Asset Chart

Apontis Pharma AG Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Equity-to-Asset
Get a 7-Day Free Trial 0.15 0.12 0.75 0.69 0.53

Apontis Pharma AG Semi-Annual Data
Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Equity-to-Asset Get a 7-Day Free Trial Premium Member Only 0.75 0.73 0.69 0.71 0.53

Competitive Comparison of Apontis Pharma AG's Equity-to-Asset

For the Drug Manufacturers - Specialty & Generic subindustry, Apontis Pharma AG's Equity-to-Asset, along with its competitors' market caps and Equity-to-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Apontis Pharma AG's Equity-to-Asset Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Apontis Pharma AG's Equity-to-Asset distribution charts can be found below:

* The bar in red indicates where Apontis Pharma AG's Equity-to-Asset falls into.



Apontis Pharma AG Equity-to-Asset Calculation

Equity to Asset ratio measures the ratios of the portion of the asset owned by shareholders out of the total asset. It indicates the leverage of the company, and the amount of debt the company uses in its operation.

Equity to Asset ratio is calculated by dividing total stockholders equity by total asset.

Apontis Pharma AG's Equity to Asset Ratio for the fiscal year that ended in Dec. 2023 is calculated as

Equity to Asset (A: Dec. 2023 )=Total Stockholders Equity/Total Assets
=30.263/57.46
=0.53

Apontis Pharma AG's Equity to Asset Ratio for the quarter that ended in Dec. 2023 is calculated as

Equity to Asset (Q: Dec. 2023 )=Total Stockholders Equity/Total Assets
=30.263/57.46
=0.53

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Apontis Pharma AG  (XTER:APPH) Equity-to-Asset Explanation

Equity to Asset ratio can vary greatly across different industries, as they have different capital structure. A company with smaller Equity to Asset ratio (more leveraged) may have higher ROE % because of the leverage.

For banks, the required minimum Equity to Asset ratio by regulation is 5%. Some stronger banks may have Equity to Asset Ratio of more than 10%.


Apontis Pharma AG Equity-to-Asset Related Terms

Thank you for viewing the detailed overview of Apontis Pharma AG's Equity-to-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.


Apontis Pharma AG (XTER:APPH) Business Description

Traded in Other Exchanges
N/A
Address
Alfred-Nobel-Strabe 10, Monheim, BY, DEU, 40789
Apontis Pharma AG is a pharmaceutical company specializing in single pills in Germany. single pills combine two to three generic active ingredients in a single dosage form. The company develops, promotes, and sells a broad portfolio of single pills and other pharmaceutical products, with a special focus on cardiovascular diseases.
Executives
Karlheinz Gast Board of Directors
Thomas Milz Board of Directors

Apontis Pharma AG (XTER:APPH) Headlines

No Headlines